Literature DB >> 22194045

Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.

W Bohle, P U Clemens, T Heubach, W G Zoller.   

Abstract

PURPOSE: HCC and CC are the most common primary malignancies of the liver. There is only minimal evidence as to whether these two entities can be reliably differentiated by contrast-enhanced ultrasound.
MATERIALS AND METHODS: We retrospectively analyzed the CEUS pattern of 39 patients with HCC, 11 patients with intrahepatic cholangiocarcinoma (ICC), 3 patients with Klatskin tumor, and 4 patients with gallbladder carcinoma. CEUS was performed using a standardized protocol (low MI, SonoVue®) with documentation of the arterial, portal-venous, and late phase. Besides the contrast enhancement compared to the adjacent normal liver tissue in every phase, the specific contrast pattern during the arterial phase (complete filling, incomplete filling of different grade, rim sign) was analyzed.
RESULTS: Most HCC and ICC showed hyperenhancement during the arterial phase, with hypoenhancement or isoenhancement in the portal-venous and late phase. Hyperenhancement during the portal-venous phase was only observed in some cases of HCC, but not in ICC. In the case of arterial hyperenhancement, HCC showed complete filling more often than ICC. In the case of incomplete filling, the area of contrast-enhanced tumor in most HCCs was larger than in ICCs. A rim sign was present in only less than half ICCs, but in no HCCs.
CONCLUSION: HCC and ICC differ to some extent in their CEUS enhancement pattern. Incomplete arterial hyperenhancement is more often seen in ICC than in HCC. A rim sign seems to be specific for ICC, but is only rarely present. However, in a case-to-case decision, due to overlapping characteristics, a reliable differentiation between the two tumor types by CEUS alone is very often not possible. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22194045     DOI: 10.1055/s-0031-1282029

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  10 in total

1.  Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.

Authors:  Fei Li; Qing Li; Yubo Liu; Jing Han; Wei Zheng; Yini Huang; Xueyi Zheng; Longhui Cao; Jian-Hua Zhou
Journal:  Eur Radiol       Date:  2019-07-11       Impact factor: 5.315

2.  Comparison between M-score and LR-M in the reporting system of contrast-enhanced ultrasound LI-RADS.

Authors:  Li-Da Chen; Si-Min Ruan; Yuan Lin; Jin-Yu Liang; Shun-Li Shen; Hang-Tong Hu; Yang Huang; Wei Li; Zhu Wang; Xiao-Yan Xie; Ming-De Lu; Ming Kuang; Wei Wang
Journal:  Eur Radiol       Date:  2018-12-19       Impact factor: 5.315

Review 3.  Contrast-Enhanced Ultrasound in the Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Controversy over the ASSLD Guideline.

Authors:  Le-Hang Guo; Hui-Xiong Xu
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

4.  Diagnosis efficacy of CEUS for hepatic inflammatory lesions.

Authors:  Yuanyuan Guo; Xiachuan Qin; Shaoxian Chen; Xuebin Liu; Peng Gu
Journal:  J Clin Lab Anal       Date:  2020-02-03       Impact factor: 2.352

5.  Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.

Authors:  Li-Da Chen; Si-Min Ruan; Jin-Yu Liang; Zheng Yang; Shun-Li Shen; Yang Huang; Wei Li; Zhu Wang; Xiao-Yan Xie; Ming-De Lu; Ming Kuang; Wei Wang
Journal:  World J Gastroenterol       Date:  2018-09-07       Impact factor: 5.742

6.  Contrast-enhanced Ultrasound Features of Intrahepatic Cholangiocarcinoma: A New Perspective.

Authors:  Tianjiao Chen; Xiaoyan Chang; Ke Lv; Yong Wang; Xianshui Fu; Li Tan; Yang Gui; Tongtong Zhou; Xueqi Chen; Yuxin Jiang
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

7.  Administration of Gemcitabine for Metastatic Adenocarcinoma during Pregnancy: A Case Report and Review of the Literature.

Authors:  M Wiesweg; S Aydin; A Koeninger; A Stein; U Schara; C van Roye; J Hense; A Welt; M Schuler
Journal:  AJP Rep       Date:  2014-02-17

8.  Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?

Authors:  Jia-Yan Huang; Jia-Wu Li; Wen-Wu Ling; Tao Li; Yan Luo; Ji-Bin Liu; Qiang Lu
Journal:  World J Gastroenterol       Date:  2020-07-21       Impact factor: 5.742

9.  Diagnostic Value of CEUS LI-RADS Version 2017 in Differentiating AFP-Negative Hepatocellular Carcinoma from Other Primary Malignancies of the Liver.

Authors:  Peihua Wang; Fang Nie; Tiantian Dong; Dan Yang; Ting Liu; Guojuan Wang
Journal:  Diagnostics (Basel)       Date:  2021-12-01

10.  Sarcomatoid hepatocellular carcinoma mimicking hepatic abscess: A case report.

Authors:  Zheng Yang; Kun Lv; Yanan Zhao; Minqiang Pan; Chao Zhang; Shumei Wei
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.